Addus HomeCare (NASDAQ:ADUS) Shares Down 6.1% – Time to Sell?

Addus HomeCare Co. (NASDAQ:ADUS) dropped 6.1% on Tuesday . The stock traded as low as $117.27 and last traded at $121.10. Approximately 21,713 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 130,611 shares. The stock had previously closed at $128.96.

Wall Street Analyst Weigh In

ADUS has been the subject of several analyst reports. Oppenheimer raised their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Stephens restated an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research report on Tuesday, August 6th. TD Cowen upped their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Royal Bank of Canada reissued an “outperform” rating and issued a $141.00 price target on shares of Addus HomeCare in a report on Tuesday, September 3rd. Finally, KeyCorp initiated coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Addus HomeCare has a consensus rating of “Moderate Buy” and an average price target of $131.38.

Addus HomeCare Trading Down 2.9 %

The business’s fifty day moving average price is $129.93 and its 200-day moving average price is $120.66. The company has a market capitalization of $2.27 billion, a P/E ratio of 28.13, a P/E/G ratio of 2.29 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.03 EPS. As a group, equities research analysts forecast that Addus HomeCare Co. will post 4.57 EPS for the current year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Esteban Lopez sold 500 shares of the business’s stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the transaction, the director now owns 3,866 shares in the company, valued at $502,695.98. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 22,917 shares of company stock worth $3,050,082 in the last three months. 4.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. UMB Bank n.a. raised its holdings in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after purchasing an additional 88 shares during the period. Quest Partners LLC bought a new position in shares of Addus HomeCare in the second quarter worth about $31,000. Farther Finance Advisors LLC grew its stake in shares of Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after acquiring an additional 366 shares during the period. Innealta Capital LLC purchased a new stake in Addus HomeCare in the 2nd quarter worth approximately $44,000. Finally, EntryPoint Capital LLC bought a new stake in Addus HomeCare during the 1st quarter worth approximately $44,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.